Niko-Petteri Nykänen

Dr. Niko-Petteri Nykänen


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Progress in Neurobiology
Verified
Journal Article
Closed access
TRThomas W. Rösler
Thomas W. Rösler
AMAmir Tayaranian Marvian
Amir Tayaranian Marvian
MBMatthias Brendel
Matthias Brendel
NNNiko-Petteri Nykänen
Niko-Petteri Nykänen
MHMatthias Höllerhage
Matthias Höllerhage
GHGünter U. Höglinger
Günter U. Höglinger

9 July 2018 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
NFNatascha Fussi
Natascha Fussi
MHMatthias Höllerhage
Matthias Höllerhage
TCTasnim Chakroun
Tasnim Chakroun
NNNiko-Petteri Nykänen
Niko-Petteri Nykänen
TRThomas W. Rösler
Thomas W. Rösler
GHGünter U. Höglinger
Günter U. Höglinger
Accumulation of pathological α-synuclein aggregates plays a major role in Parkinson’s disease. Macroautophagy is a mechanism to degrade intracellular protein aggregates by wrapping them into autophagosomes, followed by fusion with lysosomes. We had previously shown that pharmacological activation of macroautophagy protects against α-synuclein-induced toxicity in human neurons. Here, we hypothesized that inhibition of macroautophagy would aggravate α-synuclein-induced cell death.Unexpectedly, inhibition of autophagosome formation by silencing of ATG5 protected from α-synuclein-induced toxicity. Therefore, we studied alternative cellular mechanisms to compensate for the loss of macroautophagy. ATG5 silencing did not affect the ubiquitin–proteasome system, chaperone systems, chaperone-mediated autophagy, or the unfolded protein response. However, ATG5 silencing increased the secretion of α-synuclein via exosomes. Blocking exosomal secretion exacerbated α-synuclein-induced cell death.We conclude that exosomal secretion of α-synuclein is increased after impaired formation of autophagosomes to reduce the intracellular α-synuclein burden. This compensatory mechanism prevents α-synuclein-induced neuronal cell death.

1 February 2015 in Neurobiology of Aging
Verified
Journal Article
Closed access
HMHenna Martiskainen
Henna Martiskainen
JVJayashree Viswanathan
Jayashree Viswanathan
NNNiko-Petteri Nykänen
Niko-Petteri Nykänen
MKMitja Kurki
Mitja Kurki
SHSeppo Helisalmi
Seppo Helisalmi
Mikko HiltunenMikko Hiltunen
Mikko Hiltunen

15 May 2016 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
XYXu Yan
Xu Yan
NNNiko-Petteri Nykänen
Niko-Petteri Nykänen
CBCecilia A. Brunello
Cecilia A. Brunello
AHAnnakaisa Haapasalo
Annakaisa Haapasalo
MHMikko Hiltunen
Mikko Hiltunen
HHHenri J. Huttunen
Henri J. Huttunen
One of the defining pathological features of Alzheimer's disease is the intraneuronal accumulation of tau (also known as MAPT) protein. Tau is also secreted from neurons in response to various stimuli and accumulates in the cerebrospinal fluid of Alzheimer's disease patients. Tau pathology might spread from cell to cell through a mechanism involving secretion and uptake. Here, we developed an assay to follow cellular release and uptake of tau dimers. Individual silencing of ten common late-onset Alzheimer's disease risk genes in HEK293T cells expressing the tau reporters suggested that FRMD4A is functionally linked to tau secretion. FRMD4A depletion by using RNA interference (RNAi) reduced and overexpression increased tau secretion. The activity of cytohesins, interactors of FRMD4A and guanine-nucleotide-exchange factors of Arf6, was necessary for FRMD4A-induced tau secretion. Increased Arf6 and cell polarity signaling through Par6 and atypical protein kinase Cζ (aPKCζ) stimulated tau secretion. In mature cortical neurons, FRMD4A RNAi or inhibition of cytohesins strongly upregulated secretion of endogenous tau. These results suggest that FRMD4A, a genetic risk factor for late-onset Alzheimer's disease, regulates tau secretion by activating cytohesin–Arf6 signaling. We conclude that genetic risk factors of Alzheimer's disease might modulate disease progression by altering tau secretion.

3 February 2020 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
TCTasnim Chakroun
Tasnim Chakroun
VEValentin Evsyukov
Valentin Evsyukov
NNNiko-Petteri Nykänen
Niko-Petteri Nykänen
MHMatthias Höllerhage
Matthias Höllerhage
ASAndreas Schmidt
Andreas Schmidt
GHGünter U. Höglinger
Günter U. Höglinger
Aggregation of alpha-synuclein (αSyn) is a crucial event underlying the pathophysiology of synucleinopathies. The existence of various intracellular and extracellular αSyn species, including cleaved αSyn, complicates the quest for an appropriate therapeutic target. Hence, to develop efficient disease-modifying strategies, it is fundamental to achieve a deeper understanding of the relevant spreading and toxic αSyn species. Here, we describe comparative and proof-of-principle approaches to determine the involvement of αSyn fragments in intercellular spreading. We demonstrate that two different αSyn fragments (1–95 and 61–140) fulfill the criteria of spreading species. They efficiently instigate formation of proteinase-K-resistant aggregates from cell-endogenous full-length αSyn, and drive it into different aggregation pathways. The resulting aggregates induce cellular toxicity. Strikingly, these aggregates are only detectable by specific antibodies. Our results suggest that αSyn fragments might be relevant not only for spreading, but also for aggregation-fate determination and differential strain formation.

1 February 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
NNNiko-Petteri Nykänen
Niko-Petteri Nykänen
KKKai Kysenius
Kai Kysenius
PSPrasanna Sakha
Prasanna Sakha
PTPäivi Tammela
Päivi Tammela
HHHenri J. Huttunen
Henri J. Huttunen
Abnormal phosphorylation and aggregation of the microtubule-associated protein Tau are hallmarks of various neurodegenerative diseases, such as Alzheimer disease. Molecular mechanisms that regulate Tau phosphorylation are complex and currently incompletely understood. We have developed a novel live cell reporter system based on protein-fragment complementation assay to study dynamic changes in Tau phosphorylation status. In this assay, fusion proteins of Tau and Pin1 (peptidyl-prolyl cis-trans-isomerase 1) carrying complementary fragments of a luciferase protein serve as a sensor of altered protein-protein interaction between Tau and Pin1, a critical regulator of Tau dephosphorylation at several disease-associated proline-directed phosphorylation sites. Using this system, we identified several structurally distinct GABA(A) receptor modulators as novel regulators of Tau phosphorylation in a chemical library screen. GABA(A) receptor activation promoted specific phosphorylation of Tau at the AT8 epitope (Ser-199/Ser-202/Thr-205) in cultures of mature cortical neurons. Increased Tau phosphorylation by GABA(A) receptor activity was associated with reduced Tau binding to protein phosphatase 2A and was dependent on Cdk5 but not GSK3β kinase activity.